Association of interleukin‑6 (‑174 G/C) polymorphism with the prostate cancer risk: A meta‑analysis

作者: MINGYUAN YANG , CHAO LI , MING LI

DOI: 10.3892/BR.2014.300

关键词:

摘要: The aim of the present study was to determine whether interleukin-6 (IL-6) (-174 G/C) gene polymorphism correlates with prostate cancer. A meta-analysis based on former studies conducted and results suggest that there no significant association between IL-6 cancer risk. However, a recent published in January 2014 showed GG genotype may be associated an increased risk Caucasian subjects, whereas CC African-American which inconsistent studies. Databases, including PubMed, Embase, Web Science, Cochrane Library, Chinese Biomedical Literature Database Wanfang database, were searched 1994 March eligible susceptibility total 11 10,745 cases 13,473 controls fulfilled inclusion criteria subsequent assessment by two investigators. pooled odds ratio (OR) 95% confidence interval (95% CI) calculated examine associations, subgroup analyses performed according ethnicity. Overall, found risk, analysis suggested slightly under homozygote (CC vs. GG: OR, 3.43; CI, 1.01–11.71; P=0.049) recessive models GG/GC: 3.51; 1.04–11.82; P=0.042) patients. Caucasian, Asian or mixed populations five genetic stratifying for In conclusion, patients,

参考文章(41)
Andrea Discacciati, Alicja Wolk, Lifestyle and dietary factors in prostate cancer prevention. Recent results in cancer research. ,vol. 202, pp. 27- 37 ,(2014) , 10.1007/978-3-642-45195-9_3
William B Isaacs, Angelo M De Marzo, Karen S Sfanos, Infections and inflammation in prostate cancer American journal of clinical and experimental urology. ,vol. 1, pp. 3- 11 ,(2013)
William G. Nelson, Angelo M. DeMarzo, Srinivasan Yegnasubramanian, The Diet as a Cause of Human Prostate Cancer Cancer treatment and research. ,vol. 159, pp. 51- 68 ,(2014) , 10.1007/978-3-642-38007-5_4
Saška Marczi, Dalibor Šimunović, Sanja Mandić, Nevenka Miličević, Vesna Horvat, Ivan Ćosić, Josip Galić, Slobodan Mihaljević, Bojan Sudarević, Interleukin-6 polymorphism and prostate cancer risk in population of Eastern Croatia. Collegium Antropologicum. ,vol. 37, pp. 907- 911 ,(2013)
Alicia C. McDonald, Manish A. Vira, Adriana C. Vidal, Wenqi Gan, Stephen J. Freedland, Emanuela Taioli, Association between systemic inflammatory markers and serum prostate-specific antigen in men without prostatic disease-The 2001-2008 National Health and Nutrition examination survey The Prostate. ,vol. 74, pp. 561- 567 ,(2014) , 10.1002/PROS.22782
Xin Yao, Jiaqi Huang, Haihong Zhong, Nan Shen, Raffaella Faggioni, Michael Fung, Yihong Yao, Targeting interleukin-6 in inflammatory autoimmune diseases and cancers. Pharmacology & Therapeutics. ,vol. 141, pp. 125- 139 ,(2014) , 10.1016/J.PHARMTHERA.2013.09.004
Oh-Joon Kwon, Li Zhang, Michael M. Ittmann, Li Xin, Prostatic inflammation enhances basal-to-luminal differentiation and accelerates initiation of prostate cancer with a basal cell origin Proceedings of the National Academy of Sciences of the United States of America. ,vol. 111, pp. 201318157- ,(2014) , 10.1073/PNAS.1318157111
Katarina Shahedi, Sara Lindström, SL Zheng, Fredrik Wiklund, J Adolfsson, J Sun, Katarina Augustsson‐Bälter, B‐L Chang, H‐O Adami, W Liu, Henrik Grönberg, J Xu, None, Genetic variation in the COX-2 gene and the association with prostate cancer risk International Journal of Cancer. ,vol. 119, pp. 668- 672 ,(2006) , 10.1002/IJC.21864
Hongtuan Zhang, Yong Xu, Liang Li, Ranlu Liu, Baojie Ma, The interleukin-6 -174G/C polymorphism and prostate cancer risk: a systematic review and meta-analysis. Urologia Internationalis. ,vol. 88, pp. 447- 453 ,(2012) , 10.1159/000335207
Makito Miyake, Adrienne Lawton, Steve Goodison, Virginia Urquidi, Charles J. Rosser, Chemokine (C-X-C motif) ligand 1 (CXCL1) protein expression is increased in high-grade prostate cancer. Pathology Research and Practice. ,vol. 210, pp. 74- 78 ,(2014) , 10.1016/J.PRP.2013.08.013